ArticleAME case reports2026
Application of corticosteroid therapy with esophageal cancer: a case report in the treatment of radiation-induced and immune-related pneumonia.
Article in AME case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Radiation pneumonitis (RP) and immune-related pneumonitis represent frequent side effects following treatment for esophageal cancer. Addressing these conditions while minimizing the risk of chronic pulmonary fibrosis remains a significant clinical challenge. Case Description: This case report describes the management of a patient with esophageal cancer who developed interstitial pneumonia following combined radiotherapy and immunotherapy. Guided by the " Conclusions: In clinical practice, inappropriate use of corticosteroids may adversely affect patients' quality of life. This case demonstrates that a structured and individualized approach to corticosteroid management can serve as a viable strategy for mitigating severe RP and preserving functional status. However, the management of such cases remains challenging due to the high risk of complications such as pulmonary infection, particularly in patients with pre-existing lung conditions. The optimal timing, dosage, and duration of corticosteroid therapy in this context remain unclear, as no established protocol for individualized treatment currently exists in China. Thus, this case underscores a significant clinical dilemma and highlights the urgent need for further research to develop standardized, evidence-based guidelines for this patient population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.